Working… Menu
Trial record 36 of 43 for:    FLUORIDE ION AND TRICLOSAN

Meta-analysis of Stannous Fluoride and the Effects on Dental Plaque

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04006483
Recruitment Status : Completed
First Posted : July 3, 2019
Last Update Posted : July 3, 2019
Information provided by (Responsible Party):
Procter and Gamble

Brief Summary:
The aim of this 18 study analysis was to compare the effect of bioavailable stannous fluoride (SnF2) dentifrices when used up to 3 months on dental plaque relative to a positive or negative control dentifrice.

Condition or disease Intervention/treatment
Dental Plaque Drug: Stannous fluoride dentifrice Drug: Positive control dentifrice Drug: Negative control dentifrice

Layout table for study information
Study Type : Observational
Actual Enrollment : 2359 participants
Observational Model: Other
Time Perspective: Retrospective
Official Title: A Review of Meta-Analyses on Bioavailable Stannous Fluoride Dentifrices: Effects on Dental Plaque
Actual Study Start Date : January 8, 2018
Actual Primary Completion Date : November 30, 2018
Actual Study Completion Date : November 30, 2018

Resource links provided by the National Library of Medicine

Group/Cohort Intervention/treatment
Stannous Fluoride Dentifrice
Twice daily brushing
Drug: Stannous fluoride dentifrice
Stannous fluoride (0.454%) dentifrice

Positive control dentifrice
Twice daily brushing
Drug: Positive control dentifrice
Positive control dentifrice containing (0.3%) triclosan.

Negative control dentifrice
Twice daily brushing
Drug: Negative control dentifrice
Negative control dentifrice containing either sodium fluoride (0.243%) or sodium monofluorophosphate (0.76%)

Primary Outcome Measures :
  1. Dental Plaque Scores [ Time Frame: Up to 12 weeks ]
    Change from baseline as measured by mean plaque score reduction from baseline (via Quigley-Hein, Turesky Modification Index or Rustogi Modification of the Navy Plaque index).

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sampling Method:   Probability Sample
Study Population
This meta-analysis includes healthy adult male and females.

Subjects were excluded from this study for the following reasons;

  • pregnancy,
  • rampant caries,
  • severe periodontitis,
  • at discretionary of the Principal Investigator.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT04006483

Layout table for location information
United States, Ohio
Multiple P&G Investigation Clinical Sites
Cincinnati, Ohio, United States, 45040
Sponsors and Collaborators
Procter and Gamble

Layout table for additonal information
Responsible Party: Procter and Gamble Identifier: NCT04006483     History of Changes
Other Study ID Numbers: 2019SnF2PlaqueAnalysis
First Posted: July 3, 2019    Key Record Dates
Last Update Posted: July 3, 2019
Last Verified: July 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: Yes
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Dental Plaque
Dental Deposits
Tooth Diseases
Stomatognathic Diseases
Tin Fluorides
Cariostatic Agents
Protective Agents
Physiological Effects of Drugs